The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that involves the medical care of infants, children, and adolescents.This report anzlyed the medicines for pediatrics.
The global Pediatrics Medicine market was valued at US$ 161810 million in 2023 and is anticipated to reach US$ 216370 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pediatrics Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Medicine.
Report Scope
The Pediatrics Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatrics Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatrics Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- GSK
- Novartis
- Pfizer
- Sanofi
- Abbott
- Bristol-Myers Squibb
- Cipla
- Eisai Pharmaceuticals
- Eli Lilly
- F. Hoffman-La Roche
- Glenmark
- Helsinn Healthcare
- Heron Therapeutics
- Ipca Laboratories
- Lupin Pharmaceuticals
- Merck Sharp & Dohme
- RedHill
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical
Segment by Type
- Tablets
- Caplets
- Oral Liquid
- Capsules
- Other
Segment by Application
- Respiratory diseases
- Infectious diseases
- Gastrointestinal diseases
- CNS diseases
- Oncological diseases
- CVDs
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatrics Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Caplets
1.2.4 Oral Liquid
1.2.5 Capsules
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pediatrics Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory diseases
1.3.3 Infectious diseases
1.3.4 Gastrointestinal diseases
1.3.5 CNS diseases
1.3.6 Oncological diseases
1.3.7 CVDs
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatrics Medicine Market Perspective (2019-2030)
2.2 Pediatrics Medicine Growth Trends by Region
2.2.1 Global Pediatrics Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatrics Medicine Historic Market Size by Region (2019-2024)
2.2.3 Pediatrics Medicine Forecasted Market Size by Region (2025-2030)
2.3 Pediatrics Medicine Market Dynamics
2.3.1 Pediatrics Medicine Industry Trends
2.3.2 Pediatrics Medicine Market Drivers
2.3.3 Pediatrics Medicine Market Challenges
2.3.4 Pediatrics Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Revenue
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2019-2024)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatrics Medicine Revenue
3.4 Global Pediatrics Medicine Market Concentration Ratio
3.4.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2023
3.5 Pediatrics Medicine Key Players Head office and Area Served
3.6 Key Players Pediatrics Medicine Product Solution and Service
3.7 Date of Enter into Pediatrics Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatrics Medicine Breakdown Data by Type
4.1 Global Pediatrics Medicine Historic Market Size by Type (2019-2024)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030)
5 Pediatrics Medicine Breakdown Data by Application
5.1 Global Pediatrics Medicine Historic Market Size by Application (2019-2024)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatrics Medicine Market Size (2019-2030)
6.2 North America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatrics Medicine Market Size by Country (2019-2024)
6.4 North America Pediatrics Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatrics Medicine Market Size (2019-2030)
7.2 Europe Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatrics Medicine Market Size by Country (2019-2024)
7.4 Europe Pediatrics Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatrics Medicine Market Size (2019-2030)
8.2 Asia-Pacific Pediatrics Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatrics Medicine Market Size (2019-2030)
9.2 Latin America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatrics Medicine Market Size by Country (2019-2024)
9.4 Latin America Pediatrics Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatrics Medicine Market Size (2019-2030)
10.2 Middle East & Africa Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pediatrics Medicine Introduction
11.1.4 GSK Revenue in Pediatrics Medicine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatrics Medicine Introduction
11.2.4 Novartis Revenue in Pediatrics Medicine Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatrics Medicine Introduction
11.3.4 Pfizer Revenue in Pediatrics Medicine Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pediatrics Medicine Introduction
11.4.4 Sanofi Revenue in Pediatrics Medicine Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Pediatrics Medicine Introduction
11.5.4 Abbott Revenue in Pediatrics Medicine Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Pediatrics Medicine Introduction
11.7.4 Cipla Revenue in Pediatrics Medicine Business (2019-2024)
11.7.5 Cipla Recent Development
11.8 Eisai Pharmaceuticals
11.8.1 Eisai Pharmaceuticals Company Detail
11.8.2 Eisai Pharmaceuticals Business Overview
11.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
11.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.8.5 Eisai Pharmaceuticals Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Pediatrics Medicine Introduction
11.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 F. Hoffman-La Roche
11.10.1 F. Hoffman-La Roche Company Detail
11.10.2 F. Hoffman-La Roche Business Overview
11.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
11.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024)
11.10.5 F. Hoffman-La Roche Recent Development
11.11 Glenmark
11.11.1 Glenmark Company Detail
11.11.2 Glenmark Business Overview
11.11.3 Glenmark Pediatrics Medicine Introduction
11.11.4 Glenmark Revenue in Pediatrics Medicine Business (2019-2024)
11.11.5 Glenmark Recent Development
11.12 Helsinn Healthcare
11.12.1 Helsinn Healthcare Company Detail
11.12.2 Helsinn Healthcare Business Overview
11.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
11.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024)
11.12.5 Helsinn Healthcare Recent Development
11.13 Heron Therapeutics
11.13.1 Heron Therapeutics Company Detail
11.13.2 Heron Therapeutics Business Overview
11.13.3 Heron Therapeutics Pediatrics Medicine Introduction
11.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024)
11.13.5 Heron Therapeutics Recent Development
11.14 Ipca Laboratories
11.14.1 Ipca Laboratories Company Detail
11.14.2 Ipca Laboratories Business Overview
11.14.3 Ipca Laboratories Pediatrics Medicine Introduction
11.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024)
11.14.5 Ipca Laboratories Recent Development
11.15 Lupin Pharmaceuticals
11.15.1 Lupin Pharmaceuticals Company Detail
11.15.2 Lupin Pharmaceuticals Business Overview
11.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
11.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)
11.15.5 Lupin Pharmaceuticals Recent Development
11.16 Merck Sharp & Dohme
11.16.1 Merck Sharp & Dohme Company Detail
11.16.2 Merck Sharp & Dohme Business Overview
11.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
11.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024)
11.16.5 Merck Sharp & Dohme Recent Development
11.17 RedHill
11.17.1 RedHill Company Detail
11.17.2 RedHill Business Overview
11.17.3 RedHill Pediatrics Medicine Introduction
11.17.4 RedHill Revenue in Pediatrics Medicine Business (2019-2024)
11.17.5 RedHill Recent Development
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Detail
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024)
11.18.5 Sun Pharmaceutical Industries Recent Development
11.19 Takeda Pharmaceutical
11.19.1 Takeda Pharmaceutical Company Detail
11.19.2 Takeda Pharmaceutical Business Overview
11.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
11.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024)
11.19.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
